| DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer D Hessels, JMTK Gunnewiek, I van Oort, HFM Karthaus, ... European urology 44 (1), 8-16, 2003 | 1023 | 2003 |
| Prostate cancer: multiparametric MR imaging for detection, localization, and staging CMA Hoeks, JO Barentsz, T Hambrock, D Yakar, DM Somford, ... Radiology 261 (1), 46-66, 2011 | 825 | 2011 |
| Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in … M van der Leest, E Cornel, B Israel, R Hendriks, AR Padhani, ... European urology 75 (4), 570-578, 2019 | 748 | 2019 |
| Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer T Hambrock, DM Somford, HJ Huisman, IM van Oort, JA Witjes, ... Radiology 259 (2), 453-461, 2011 | 726 | 2011 |
| Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen T Hambrock, DM Somford, C Hoeks, SAW Bouwense, H Huisman, ... The Journal of urology 183 (2), 520-528, 2010 | 473 | 2010 |
| Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer GHJM Leyten, D Hessels, SA Jannink, FP Smit, H de Jong, EB Cornel, ... European urology 65 (3), 534-542, 2014 | 471 | 2014 |
| Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility J Gudmundsson, P Sulem, DF Gudbjartsson, T Blondal, A Gylfason, ... Nature genetics 41 (10), 1122-1126, 2009 | 439 | 2009 |
| Detection of high-grade prostate cancer using a urinary molecular biomarker–based risk score L Van Neste, RJ Hendriks, S Dijkstra, G Trooskens, EB Cornel, ... European urology 70 (5), 740-748, 2016 | 427 | 2016 |
| Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging–guided biopsies versus a systematic 10-core transrectal … T Hambrock, C Hoeks, C Hulsbergen-Van De Kaa, T Scheenen, J Fütterer, ... European urology 61 (1), 177-184, 2012 | 385 | 2012 |
| Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019 S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ... European urology 77 (4), 508-547, 2020 | 376 | 2020 |
| A germline variant in the TP53 polyadenylation signal confers cancer susceptibility SN Stacey, P Sulem, A Jonasdottir, G Masson, J Gudmundsson, ... Nature genetics 43 (11), 1098-1103, 2011 | 323 | 2011 |
| Identification of a candidate gene panel for the early diagnosis of prostate cancer GHJM Leyten, D Hessels, FP Smit, SA Jannink, H de Jong, WJG Melchers, ... Clinical cancer research 21 (13), 3061-3070, 2015 | 260 | 2015 |
| A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer J Gudmundsson, P Sulem, DF Gudbjartsson, G Masson, BA Agnarsson, ... Nature genetics 44 (12), 1326-1329, 2012 | 236 | 2012 |
| The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer DM Somford, EH Hamoen, JJ Fütterer, JP Van Basten, ... The Journal of urology 190 (5), 1728-1734, 2013 | 218 | 2013 |
| Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial JS de Bono, N Mehra, GV Scagliotti, E Castro, T Dorff, A Stirling, A Stenzl, ... The Lancet Oncology 22 (9), 1250-1264, 2021 | 214 | 2021 |
| Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy JT Plukker, I Van Oort, A Vermey, I Molenaar, HJ Hoekstra, AK Panders, ... Journal of British Surgery 82 (4), 510-514, 1995 | 197 | 1995 |
| Genetic correction of PSA values using sequence variants associated with PSA levels J Gudmundsson, S Besenbacher, P Sulem, DF Gudbjartsson, I Olafsson, ... Science translational medicine 2 (62), 62ra92-62ra92, 2010 | 187 | 2010 |
| The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact LF van Dessel, J van Riet, M Smits, Y Zhu, P Hamberg, ... Nature communications 10 (1), 5251, 2019 | 179 | 2019 |
| Randomized trial comparing the Prolene® Hernia System, mesh plug repair and Lichtenstein method for open inguinal hernia repair SW Nienhuijs, I Van Oort, ME Keemers-Gels, LJA Strobbe, C Rosman Journal of British Surgery 92 (1), 33-38, 2005 | 178 | 2005 |
| Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration‐resistant prostate cancer who progress after docetaxel and abiraterone … S Badrising, V van der Noort, IM van Oort, HP van den Berg, M Los, ... Cancer 120 (7), 968-975, 2014 | 160 | 2014 |
